Literature review helped us identify potential binding partners (CRTH2, TMEM219, and IL13Rα2) and their expression in both non-neoplastic and glioblastoma tissue was analyzed based on data from The Cancer Genome Atlas Program (TCGA) database (Figure 3h). This evidence concerns the gene IL13RA2 and glioblastoma.